Do you want to read an article? Please log in or register.
Oncological Outcomes of Non-Muscle Invasive Bladder Cancer in Patients Aged ≤45: A Retrospective Matched Cohort Study
Genitourinary Cancer
Related content
Genitourinary Cancer
Individual Patient Data Validation of the EAU Definitions of BCG Failure in Patients with Non-muscle-invasive Urothelial Carcinoma of the Bladder: An International Multicenter Retrospective Study
Eur Urol Oncol
Gontero P, Soria F, Babjuk M, Burger M, Palou Redorta J, D'Andrea D, Pradere B, Moschini M, Birtle A, Compérat EM, Dominguez-Escrig JL, Liedberg F, Mariappan P, van Rhijn BWG, Seisen T, Shariat SF, Teoh J, Xylinas E, Capoun O, Rai BP, Soukup V, Faba OR, Cohen D, Foster L, Beaud N, Girtner F, Breyer J, Hornak J, Einerhand SMH, Anract J, Bobjer J, Linares E, Rodriguez-Serranos A, Cathomas R, Saba K, Hernandez V, Lorente C, Rouanne M, Lebret T, Masson-Lecomte A, Rouprêt M, Sylvester RJ
doi: 10.1016/j.euo.2026.05.005
COMMENTED
Genitourinary Cancer
Twelve-Month Results From the CISTO Study Comparing Radical Cystectomy Versus Bladder-Sparing Therapy for Recurrent High-Grade Non-Muscle-Invasive Bladder Cancer
★ 1
Recommended and commented by
Prof. Dr Richard Cathomas, Faculty Member
J Clin Oncol
Gore JL, Wolff EM, Nash MG, Comstock BA, Gilbert SM, Chang SS, Chisolm S, MacLean DB, Wright JL, Kates MR, Pohar KS, Guzzo TJ, Bivalacqua TJ, Nepple KG, Montgomery JS, Scarpato KR, Woldu SL, Master VA, Chen DYT, Mossanen M, Daneshmand S, O'Neil BB, Tyson MD, Westerman ME, Kamat AM, Mansour AM, Chamie K, Riggs SB, Kukreja JB, Modi PK, Garg T, Peyton CC, Nix JW, Dickstein R, Gadzinski AJ, Sankin A, Shore ND, Lane BR, Bassett JC, Patel S, Morris DS, Macleod LC, Lee EK, Ritch CR, Follmer KM, Lee JR, Kim SM, Kessler LG, Smith AB, CISTO Collaborative group
doi: 10.1200/JCO-25-01324
Lung, Respiratory and Thoracic Cancer
Upfront osimertinib and as sequential therapy in patients with EGFR-mutant non-small cell lung cancer (NSCLC): benefit across patients groups in a real-world retrospective cohort-the smile study
Transl Lung Cancer Res
Auclin E, Du Rusquec P, Albarran-Artahona V, Aboubakar F, Gerber H, Epaillard N, Recondo G, De Giglio A, Berthou H, Laguna JC, Gorria T, Blaquier JB, Jimenez-Munarriz B, Tagliamento M, Di Federico A, Sacco G, Minatta J, Girard N, Moran-Bueno T, Lopez-Castro R, Besse B, Mezquita L
doi: 10.21037/tlcr-24-881
Genitourinary Cancer
Long-term outcomes of a cascading salvage strategy for high-risk non-muscle-invasive bladder cancer
BJU Int
McElree IM, Steinberg RL, Hougen HY, Mott SL, Packiam VT, O'Donnell MA
doi: 10.1111/bju.70044
Genitourinary Cancer
Long-term outcomes following a 5-year recurrence-free interval in non-muscle-invasive bladder cancer
BJU Int
Hjort PB, Jensen JB, Ernst A
doi: 10.1111/bju.70267
Genitourinary Cancer
Impact of American Urological Association risk category on outcomes of intravesical BCG vs gemcitabine/docetaxel in high-grade Ta non-muscle-invasive bladder cancer
BJU Int
Abou Chakra M, McElree IM, Mott SL, O'Donnell MA
doi: 10.1111/bju.70149
Lung, Respiratory and Thoracic Cancer
European experience on oncological outcomes of patients with early-stage non-small cell lung cancer and any prior cancer following lobectomy or segmentectomy
Lung Cancer
Lula LJ, Costa R, Huang L, Rushwan A, Domjan M, Franssen AJPM, Weedle R, Trabalza Marinucci B, Barreda CF, Jasovic C, Whooley J, Matache RS, Özgür EG, Ryan R, Young V, Tahiri M, Fernandes P, Rendina EA, Bekiroglu N, de Loos ER, Jimenez M, Savu C, Bolca C, Stupnik T, Fitzmaurice GJ, D'Andrilli A, Brunelli A, Petersen RH
doi: 10.1016/j.lungcan.2026.109410
Skin Cancer
Outcome of systemic therapy in patients with advanced rare skin cancers: A retrospective multicenter DeCOG study of 209 patients
Eur J Cancer
Ugurel S, Abu Rached N, Gambichler T, Mengoni M, Tüting T, Hassel JC, Reschke R, Lodde GC, Placke JM, Schadendorf D, Reinhardt L, Kreuter A, Gschnell M, Utikal J, Erdmann M, Dücker P, Helbig D, Franklin C, Gebhardt C, Poch G, Kähler KC, Weichenthal M, Gutzmer R, Heinzerling L, Weishaupt C, Mohr P, Thoms KM, Lang B, Schilling B, Haferkamp S, Sachse M, Welzel J, Jochims F, Raap U, Schley G, Terheyden P, Dippel E, Pöttgen C, Becker JC, Tasdogan A, Amaral T, Nanz L, Leiter U
doi: 10.1016/j.ejca.2025.115750
Genitourinary Cancer
Urine tumor DNA testing identifies recurrence and monitors therapy response in patients with high-risk non-muscle-invasive bladder cancer receiving intravesical bacillus Calmette-Guérin
J Urol
Bahlburg H, Maas M, Contreras-Sanz A, Othman D, St-Laurent MP, Nikkola J, Chai S, Phillips KG, Hamlington B, Lentz PS, Lumbres NP, Bicocca VT, Jalanko T, Levin TG, Lange D, Black PC
doi: 10.1097/JU.0000000000005130